96 related articles for article (PubMed ID: 23093572)
1. Barriers to the diagnosis and treatment of venous thromboembolism in advanced cancer patients: a qualitative study.
Sheard L; Prout H; Dowding D; Noble S; Watt I; Maraveyas A; Johnson M
Palliat Med; 2013 Apr; 27(4):339-48. PubMed ID: 23093572
[TBL] [Abstract][Full Text] [Related]
2. The ethical decisions UK doctors make regarding advanced cancer patients at the end of life--the perceived (in) appropriateness of anticoagulation for venous thromboembolism: a qualitative study.
Sheard L; Prout H; Dowding D; Noble S; Watt I; Maraveyas A; Johnson M
BMC Med Ethics; 2012 Sep; 13():22. PubMed ID: 22947200
[TBL] [Abstract][Full Text] [Related]
3. Role of palliative low-molecular-weight heparin for treating venous thromboembolism in patients with advanced cancer.
Tran QN
Am J Hosp Palliat Care; 2010 Sep; 27(6):416-9. PubMed ID: 20197558
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis and management of people with venous thromboembolism and advanced cancer: how do doctors decide? A qualitative study.
Johnson MJ; Sheard L; Maraveyas A; Noble S; Prout H; Watt I; Dowding D
BMC Med Inform Decis Mak; 2012 Jul; 12():75. PubMed ID: 22818215
[TBL] [Abstract][Full Text] [Related]
5. [Cancer and venous thromboembolism].
Meyer G; Belmont L
Rev Mal Respir; 2011 Apr; 28(4):443-52. PubMed ID: 21549900
[TBL] [Abstract][Full Text] [Related]
6. Anticoagulant use in patients with cancer associated venous thromboembolism: a retrospective cohort study.
Rahme E; Feugère G; Sirois C; Weicker S; Ramos E
Thromb Res; 2013 Mar; 131(3):210-7. PubMed ID: 23290095
[TBL] [Abstract][Full Text] [Related]
7. Venous thromboembolism in patients with advanced cancer under palliative care: additional risk factors, primary/secondary prophylaxis and complications observed under normal clinical practice.
Soto-Cárdenas MJ; Pelayo-García G; Rodríguez-Camacho A; Segura-Fernández E; Mogollo-Galván A; Giron-Gonzalez JA
Palliat Med; 2008 Dec; 22(8):965-8. PubMed ID: 18952751
[TBL] [Abstract][Full Text] [Related]
8. Lessons from French National Guidelines on the treatment of venous thrombosis and central venous catheter thrombosis in cancer patients.
Farge D; Durant C; Villiers S; Long A; Mahr A; Marty M; Debourdeau P;
Thromb Res; 2010 Apr; 125 Suppl 2():S108-16. PubMed ID: 20433988
[TBL] [Abstract][Full Text] [Related]
9. VTE in patients with cancer--diagnosis, prevention, and treatment.
Lee A
Thromb Res; 2008; 123 Suppl 1():S50-4. PubMed ID: 18824256
[TBL] [Abstract][Full Text] [Related]
10. Acceptability of low molecular weight heparin thromboprophylaxis for inpatients receiving palliative care: qualitative study.
Noble SI; Nelson A; Turner C; Finlay IG
BMJ; 2006 Mar; 332(7541):577-80. PubMed ID: 16459340
[TBL] [Abstract][Full Text] [Related]
11. The use of long-term low-molecular weight heparin for the treatment of venous thromboembolism in palliative care patients with advanced cancer: a case series of sixty two patients.
Noble SI; Hood K; Finlay IG
Palliat Med; 2007 Sep; 21(6):473-6. PubMed ID: 17846086
[TBL] [Abstract][Full Text] [Related]
12. Venous thromboembolism: What pharmacists know? What do they need?
Rey JB; Jovenin N; Kreit P; Sicard J; Parent D; Hettler D; Nguyen P; Ducrocq JL
J Oncol Pharm Pract; 2016 Feb; 22(1):135-41. PubMed ID: 25425008
[TBL] [Abstract][Full Text] [Related]
13. How has the impact of 'care pathway technologies' on service integration in stroke care been measured and what is the strength of the evidence to support their effectiveness in this respect?
Allen D; Rixson L
Int J Evid Based Healthc; 2008 Mar; 6(1):78-110. PubMed ID: 21631815
[TBL] [Abstract][Full Text] [Related]
14. [Cancer and venous thromboembolism].
Meyer G
J Mal Vasc; 2011 Dec; 36 Suppl 1():S42-7. PubMed ID: 22177769
[TBL] [Abstract][Full Text] [Related]
15. A review of the practical advantages of low molecular weight heparin in the treatment of cancer-related venous thromboembolism.
Rhodes S; Bond S
Eur J Oncol Nurs; 2008 Dec; 12(5):425-9. PubMed ID: 18842458
[TBL] [Abstract][Full Text] [Related]
16. The role of low-molecular-weight heparins as supportive care therapy in cancer-associated thrombosis.
Cunningham RS
Semin Oncol; 2006 Apr; 33(2 Suppl 4):S17-25; quiz S41-2. PubMed ID: 16638457
[TBL] [Abstract][Full Text] [Related]
17. Anticoagulation in the treatment of established venous thromboembolism in patients with cancer.
Lee AY
J Clin Oncol; 2009 Oct; 27(29):4895-901. PubMed ID: 19738121
[TBL] [Abstract][Full Text] [Related]
18. Antithrombotic therapy and survival in cancer patients.
Kakkar AK
Best Pract Res Clin Haematol; 2009 Mar; 22(1):147-51. PubMed ID: 19285281
[TBL] [Abstract][Full Text] [Related]
19. Treatment of venous thromboembolism in cancer patients.
Petralia GA; Kakkar AK
Semin Thromb Hemost; 2007 Oct; 33(7):707-11. PubMed ID: 18000799
[TBL] [Abstract][Full Text] [Related]
20. Effects of a low-molecular-weight heparin on thrombus regression and recurrent thromboembolism in patients with deep-vein thrombosis.
Breddin HK; Hach-Wunderle V; Nakov R; Kakkar VV;
N Engl J Med; 2001 Mar; 344(9):626-31. PubMed ID: 11228276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
